Beta-adrenergic blockade in the control of schizophrenic symptoms--a case for controlled studies.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol